Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M92,503Revenue (TTM) $M19,427Net Margin (%)22.9Altman Z-Score--
Enterprise Value $M92,503EPS (TTM) $2.7Operating Margin %23.8Piotroski F-Score--
P/E(ttm)21.3Beneish M-Score--Pre-tax Margin (%)30.3Higher ROA y-yN
Price/Book6.110-y EBITDA Growth Rate %-3.4Quick Ratio--Cash flow > EarningsN
Price/Sales4.95-y EBITDA Growth Rate %-3.2Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow167y-y EBITDA Growth Rate %136ROA % (ttm)13.8Higher Current Ratio y-yN
Dividend Yield %2.7PEG--ROE % (ttm)30.2Less Shares Outstanding y-yN
Payout Ratio %76.0Shares Outstanding M1,671ROIC % (ttm)21.0Gross Margin Increase y-yN

Gurus Latest Trades with BMY

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

BMY is held by these investors:

BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ANDREOTTI LAMBERTODirector 2016-09-08Sell21,600$56.87-2.67view
ANDREOTTI LAMBERTODirector 2016-08-25Sell23,200$59.17-6.46view
ANDREOTTI LAMBERTODirector 2016-07-08Sell23,200$74.45-25.65view
ANDREOTTI LAMBERTODirector 2016-06-28Sell23,200$72.14-23.27view
Elicker John ESVP, Public Affairs & IR 2016-06-14Sell11,820$72.69-23.85view
Bancroft Charles AEVP & CFO 2016-05-20Sell30,201$70.79-21.81view
Caldarella Joseph CSVP & Controller 2016-05-16Sell3,519$72.47-23.62view
LEUNG SANDRAEVP, General Counsel 2016-05-06Sell72,544$70.39-21.37view
ANDREOTTI LAMBERTODirector 2016-05-05Sell23,200$70.54-21.53view
Caforio GiovanniCEO 2016-05-03Sell34,594$71.31-22.38view

Press Releases about BMY :

Quarterly/Annual Reports about BMY:

News about BMY:

Articles On GuruFocus.com
David Tepper Invests Heavily in Pharma in 4th Quarter Feb 16 2017 
Baron Funds' Fifth Avenue Growth Fund Comments on Bristol-Myers Squibb Company Feb 13 2017 
Dodge & Cox Comments on Bristol-Myers Squibb Feb 01 2017 
Dodge & Cox's Stock Fund 4th Quarter Letter to Shareholders Feb 01 2017 
Is Bristol-Meyers a Buy After 39% Price Decline? Jan 29 2017 
Stocks Reach Their 3-Year Low Prices Jan 28 2017 
Manning & Napier’s Top 3 New Holdings Jan 26 2017 
52-Week Company Lows Jan 26 2017 
Biotech Stocks to Watch After Senate Drug Report Dec 27 2016 
Looking for Moat Stocks Dec 20 2016 

More From Other Websites
Bristol-Myers Squibb Prices $1.5 Billion of Senior Notes Feb 22 2017
Bristol Myers' Future Unsure as Carl Icahn Takes Stake Feb 22 2017
S&P 500 Trades Lower as Fed Signals Move on Rates 'Fairly Soon' Feb 22 2017
US STOCKS-S&P, Nasdaq dip ahead of Fed minutes; Dow hits record high Feb 22 2017
Carl Icahn Takes Stake in Bristol-Myers Squibb Feb 22 2017
This bullish stock signal has never been wrong — and it’s about to flash for 2017 Feb 22 2017
Carl Icahn just jumped into a $90 billion drug maker, and people are betting it'll be a takeover... Feb 22 2017
US STOCKS-Wall St slightly lower ahead of Fed minutes Feb 22 2017
Dow Turns Positive in Wishy-Washy Trading Ahead of Fed Minutes Feb 22 2017
Takeover speculation surrounds Bristol-Myers Squibb Feb 22 2017
DISH tunes in solid profits, Toll builds on earnings & Carl Icahn eyes Bristol-Myers Squibb Feb 22 2017
Bristol-Myers Squibb Company -- Moody's rates Bristol's notes A2; negative outlook Feb 22 2017
Merck & Co.’s Segment-Wise Revenues for 4Q16 Feb 22 2017
Stock Futures Waver as Wall Street Awaits Clarity From the Fed Feb 22 2017
Carl Icahn's Next Target: Bristol-Myers Squibb Feb 22 2017
Fed minutes in focus Feb 22 2017
Stock market set to lose grip on records as Fed minutes loom Feb 22 2017
Is Carl Icahn Targeting Bristol-Myers Squibb for a Takeover? Feb 22 2017
U.S. stocks on pause after record rally, with Fed minutes ahead Feb 22 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)